Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing...
Month: March 2024
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Castle’s presentations at AAD include the latest findings from the Company’s ongoing collaboration with the National Cancer Institute’s Surveillance, Epidemiology,...
Ainos Reports Full Year 2023 Financial Results
Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024 Advancing VELDONA drug candidates to Phase III clinical...
Ainos Reports Full Year 2023 Financial Results
Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024 Advancing VELDONA drug candidates to Phase III clinical...
Landsea Homes Announces Closing of Secondary Common Stock Offering
DALLAS, March 08, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded...
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Contacts Investor and Media Contact: Gitanjali Jain Vice President, Investor Relations and External Affairs Kezar Life Sciences, Inc. gjain@kezarbio.com Kezar...
Hudson Global to Report Fourth Quarter 2023 Financial Results on March 14th
OLD GREENWICH, Conn., March 08, 2024 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company,...
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel...
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company...
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts Investors: Nareg Sagherian Vice President, Head of Global Investor Relations and Corporate Communications Tel: 248-202-9267 Email: ir@evolus.com Media: Email:...
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
Fangdd unveils 2024 strategic layout, aims to enter the real estate stock asset services sector
SHENZHEN, China, March 08, 2024 (GLOBE NEWSWIRE) -- Due to urbanization slowdown and per capita housing saturation in China, the...
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA, March 08, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for...
PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
VANCOUVER, British Columbia, March 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF),...
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
RenovoRx Highlights Key Leadership Promotions
Company has promoted Leesa Gentry to Chief Clinical Officer and Ronald B. Kocak to Principal Accounting Officer Contacts Investor Contact:...
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Recently presented positive Phase 1 clinical trial data for PSMA-TRACTr JANX007 in mCRPC and for EGFR-TRACTr JANX008 in solid tumors...
Sonendo Announces Departure of Chief Financial Officer
Contacts Investor Contact: Gilmartin Group Greg Chodaczek IR@Sonendo.com Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer...
The Honest Company to Participate in the UBS Global Consumer and Retail Conference on March 14, 2024
LOS ANGELES, March 08, 2024 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating...
Rackspace Technology gibt am Dienstag, den 12. März 2024, die Erträge für das vierte Quartal und das Gesamtjahr 2023 bekannt
SAN ANTONIO, March 08, 2024 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), ein führender Anbieter von hybriden, End-to-End-, Multicloud- und KI-Lösungen,...
Methanex Releases 2023 Sustainability Report
VANCOUVER, British Columbia, March 08, 2024 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (NASDAQ:MEOH) released its 2023 Sustainability Report today to...
Daktronics to Present at Sidoti Small-Cap Virtual Conference March 13-14
BROOKINGS, S.D., March 08, 2024 (GLOBE NEWSWIRE) -- Daktronics Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class...
Dime Continues Sponsorship for Sunrise Day Camp
HAUPPAUGE, N.Y., March 08, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent...
Dime Continues Sponsorship for Sunrise Day Camp
HAUPPAUGE, N.Y., March 08, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent...
CORRECTING and REPLACING CIBL, Inc. Reports Preliminary (Unaudited) Fourth Quarter and Full Year 2023 Operating Results
Contacts Kenneth D. Masiello Chief Financial Officer (775) 664-3700 In the release dated March 6, 2024, second sentence of second...
bettermoo(d) CEO to Host Special Investors Announcement on Wednesday, March 13, 2024
VANCOUVER, BC / ACCESSWIRE / March 8, 2024 / bettermoo(d) Food Corporation (the "Company" or "bettermoo(d)") is pleased to announce...
Regency Silver Closes Further Tranche of Private Placement, Announces Extension of Private Placement and Grant of Stock Options
VANCOUVER, BC / ACCESSWIRE / March 8, 2024 / Regency Silver Corp. ("Regency Silver" or the "Company", (TSXV:RSMX) and (OTCQB:RSMXF)...
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
JERSEY CITY, N.J., March 8, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution...
Technology & FinTech Leaders CREATD and TAMI Ventures Inc., Plan to Combine Forces in $23 Million Transaction
NEW YORK, March 8, 2024 /PRNewswire/ -- Creatd, Inc. (OTCQB:CRTD), a leading innovator in digital technology and creator-centric platforms based...
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
Contacts Investor Contacts: Pulse Biosciences Kevin Danahy, President and CEO 510.241.1077 IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com...
Sun Peak Metals Grants Stock Options
VANCOUVER, BC / ACCESSWIRE / March 8, 2024 / Sun Peak Metals Corp. (the "Company" or "Sun Peak") (TSXV:PEAK)(OTCQB:SUNPF) reports...
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
Contacts bioAffinity Technologies Julie Anne Overton Director of Communications jao@bioaffinitytech.com Investor Relations Dave Gentry RedChip Companies Inc. 1-800-RED-CHIP (733-2447) or...
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
Contacts bioAffinity Technologies Julie Anne Overton Director of Communications jao@bioaffinitytech.com Investor Relations Dave Gentry RedChip Companies Inc. 1-800-RED-CHIP (733-2447) or...
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
- Stock trades significantly below its net cash per share. - The board is arguably in breach of their fiduciary...
Asure Reports Q4 2023 and FY 2023 Financial Results Highlighting Revenue Growth Excluding ERTC
AUSTIN, TX / ACCESSWIRE / March 8, 2024 / Asure Software, Inc. (NASDAQ:ASUR) ("Asure" or "the Company"), a provider of...
NeuroOne® to Participate in the 36th Annual Roth Conference
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a...
Leatt Announces Date of Fourth Quarter and Full Year 2023 Results Conference Call and Webcast
CAPE TOWN, South Africa, March 8, 2024 /PRNewswire/ -- Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe...
LIBERTY LATIN AMERICA JOINS THE WEPS COMMUNITY DEMONSTRATING COMMITMENT TO WOMEN’S EQUALITY
Contacts Investor Relations: Kunal Patel ir@lla.com Media Relations: Kim Larson llacommunications@lla.com This International Women’s Day, Liberty Latin America Ltd. (“Liberty...